cp wire

CP Wire Articles

FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications

Pfizer Inc. (NYSE:PFE) announced on 5/29/18 that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Xalkori (crizotinib) for the treatment of patients with... read more

Tue, 05/29/18 - 10:14 am
More Good News for Bicycle Therapeutics
  • Bicycle receives milestone payment associated with phase I initiation
  • Expands alliance with ThromboGenics
  • Announced expanded partnership with AstraZeneca on 5/24/18
    • ... read more
Fri, 05/25/18 - 09:11 am
AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
  • Imfinzi has met both primary endpoints in Pacific trial
  • AstraZeneca will seek expanded labeling
  • Imfinzi currently approved for treatment of patients with unresectable Stage... read more
Fri, 05/25/18 - 08:59 am
BioMarin Rises on Approval of Palynziq (pegvaliase-pqpz)

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced on 5/24/18 that BioMarin received standard approval from the U.S. Food and Drug Administration (FDA) for Palynziq (pegvaliase-pqpz) Injection... read more

Fri, 05/25/18 - 08:45 am
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

Bicycle Therapeutics, announced on 5/24/18 that it is expanding its collaboration with AstraZeneca to include additional targets in respiratory and cardio-metabolic diseases.

The original... read more

Thu, 05/24/18 - 09:20 am

Pages